Market Cap 11.20M
Revenue (ttm) 18.16M
Net Income (ttm) -20.13M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -110.85%
Debt to Equity Ratio 0.09
Volume 352,900
Avg Vol 9,273,876
Day's Range N/A - N/A
Shares Out 31.06M
Stochastic %K 30%
Beta -0.02
Analysts Strong Sell
Price Target $4.00

Latest News on IPA

ImmunoPrecise Antibodies Announces Key Leadership Changes

Feb 24, 2025, 8:01 AM EST - 5 weeks ago

ImmunoPrecise Antibodies Announces Key Leadership Changes


IPA Announces Resignation of Chief Financial Officer

Dec 31, 2024, 7:56 PM EST - 3 months ago

IPA Announces Resignation of Chief Financial Officer


IPA to Present at The Microcap Conference 2025

Dec 19, 2024, 10:15 AM EST - 3 months ago

IPA to Present at The Microcap Conference 2025


ImmunoPrecise Appoints Kristin Taylor as Chief Financial Officer

Jun 27, 2024, 8:01 AM EDT - 9 months ago

ImmunoPrecise Appoints Kristin Taylor as Chief Financial Officer